logo

For the Inventor, By the Inventor

Heverlee/Leuven, Belgium

Thrombogenics Nv


USPTO Granted Patents = 21



Trademarks = 1

Forward Citations = 82

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Marc De Smet (10 out of 10 patents)

silverMedal Steve Pakola (10 out of 10 patents)

bronzeMedal Jean-Marie Stassen (4 out of 6 patents)

4.  Peter Carmeliet (3 out of 21 patents)

5.  Richard Reinier Zwaal (3 out of 4 patents)

6.  Désiré Collen (3 out of 10 patents)

7.  Ingeborg Stalmans (2 out of 2 patents)

8.  Luc Schoonjans (2 out of 3 patents)

9.  Claudia Fromond (1 out of 6 patents)

10.  Hoa Thu Ngo (1 out of 1 patent)

11.  Sofie Notebaert (1 out of 1 patent)

12.  Emmanuel Sneyders (1 out of 1 patent)

13.  Jean Marie Stassen (1 out of 1 patent)

14.  Hans Nicasy (1 out of 1 patent)

15.  Bart Jonckx (1 out of 1 patent)


21 patents:

1. 9884910 - Anti-PDGF-C antibodies (2018-02-06),
2. 9770494 - Pharmacological vitreolysis (2017-09-26),
3. 9644196 - Plasminogen and plasmin variants (2017-05-09),
4. 9445078 - Stereo-vision system (2016-09-13),
5. 9226953 - Variants of plasminogen and plasmin (2016-01-05),
6. 9186394 - Pharmacological vitreolysis (2015-11-17),
7. 9089552 - Improving trabeculectomy outcome by administering an anti-placental growth factor antibody (2015-07-28),
8. 9085617 - Anti-angiogenic therapy (2015-07-21),
9. 8993323 - Compositions for the in vitro derivation and culture of embryonic stem (ES) cell lines with germline transmission capability and for the culture of adult stem cells (2015-03-31),
10. 8920794 - Method for treating filtration failure after trabeculectomy surgery (2014-12-30),
11. 8834869 - Pharmacological vitreolysis (2014-09-16),
12. 8758748 - Anti-angiogenic therapy (2014-06-24),
13. 8747842 - Pharmacological vitreolysis (2014-06-10),
14. 8697444 - Compositions for the in vitro derivation and culture of embryonic stem (ES) cell lines with germline transmission capability and for the culture of adult stem cells (2014-04-15),
15. 8460655 - Pharmacological vitreolysis (2013-06-11),
ThromboGenics NV is a biopharmaceutical company focused on developing innovative treatments for eye diseases. They specialize in the research and development of novel therapies for diabetic eye disease, including diabetic retinopathy. ThromboGenics NV's mission is to improve the quality of life for patients with retinal conditions by delivering effective and safe treatment options. For more information, visit their website.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

21 Patents

#1 in Heverlee/Leuven

#157 in Belgium

#29,080 in the World

...
Heverlee/Leuven, Belgium

Thrombogenics Nv

Forward Citations = 82

16 inventors:

goldMedal Marc De Smet (10 out of 10 patents)

silverMedal Steve Pakola (10 out of 10 patents)

bronzeMedal Jean-Marie Stassen (4 out of 6 patents)

4.  Peter Carmeliet (3 out of 21 patents)

5.  Richard Reinier Zwaal (3 out of 4 patents)

Please report any incorrect information to support@idiyas.com
Loading…